Stock Events

Stock Events

Search...

Allogene Therapeutics (ALLO) Q2 2023 Earnings

2AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.7

-0.64

-0.59

-0.53

Details

Expected EPS

-0.59

Actual EPS

-0.53

Surprise EPS

0.06

Surprise Percent

+10.17%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.53 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.